Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00136565
Recruitment Status : Unknown
Verified November 2007 by Lymphoma Study Association.
Recruitment status was:  Active, not recruiting
First Posted : August 29, 2005
Last Update Posted : November 8, 2007
Janssen-Cilag International NV
Information provided by:
Lymphoma Study Association